« Previous
Next »
Urology
Volume 64, Issue 2
, Pages
317-322
, August 2004
Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening
To access this article, please choose from the options below
☆ This research was funded by NHS South and West R&D; and the ProtecT treatment trial was funded by the NHS Health Technology Assessment Programme.
PII: S0090-4295(04)00335-8
doi: 10.1016/j.urology.2004.03.018
© 2004 Elsevier Inc. All rights reserved.
« Previous
Next »
Urology
Volume 64, Issue 2
, Pages
317-322
, August 2004
